GgoogleDE first seen 12 h ago, last 10 h ago, peak #2
OpenAI acquires drug development tool to speed research
Original: open ai
OpenAI has acquired a tool designed to accelerate drug development workflows, a field where research and testing are notoriously slow. The move signals OpenAI's push to apply its artificial intelligence beyond chatbots and into pharmaceutical research, where AI could shorten discovery timelines and reduce costs. Industry watchers see it as part of a broader race among AI companies to expand into science and healthcare applications.
Why now: People are discussing OpenAI's expansion into healthcare and drug discovery following the acquisition news.
Rank over time, top of the chart is #1. 11 snapshots from 12 h ago to 10 h ago.
Evidence
- OpenAI acquires drug tool to speed slow drug development workflows · Interesting Engineering
- OpenAI Buys Drug Development Company Orchestra Bio · The Information
- OpenAI Acquisition of Orchestra Bio Shakes Veeva Systems (VEEV) Stock · GuruFocus
- Judge Dismisses Sexual Abuse Lawsuit Against Sam Altman Brought By His Sister · Forbes
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/3037178